These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 29265920)
1. Preparation of Radioactive Skin Patches Using Polyhydroxamic Acid-Grafted Cellulose Films Toward Applications in Treatment of Superficial Tumors. Saxena SK; Kumar Y; Shaikh SH; Pandey U; Kumar SA; Dash A Cancer Biother Radiopharm; 2017 Dec; 32(10):364-370. PubMed ID: 29265920 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and Preliminary Biological Evaluation of Pandey U; Subramanian S; Shaikh S; Gamre N; Kumar S; Dash A Cancer Biother Radiopharm; 2019 Jun; 34(5):306-315. PubMed ID: 31188652 [No Abstract] [Full Text] [Related]
3. A facile, viable approach toward the preparation of 32p patches for the treatment of skin cancer. Saxena SK; Kumar Y; Pandey U; Shinde SN; Muthe KP; Venkatesh M; Dash A Cancer Biother Radiopharm; 2011 Oct; 26(5):665-70. PubMed ID: 21834650 [TBL] [Abstract][Full Text] [Related]
4. Nafion-zirconium phosphate composite membrane: a new approach to prepare (32)P patches for superficial brachytherapy applications. Saxena SK; Kumar Y; Dash A Cancer Biother Radiopharm; 2012 May; 27(4):276-84. PubMed ID: 22594906 [TBL] [Abstract][Full Text] [Related]
5. On the application of Nafion membrane for the preparation of (90)Y skin patches, quality control, and biological evaluation for treatment of superficial tumors. Saxena SK; Pandey U; Kumar Y; Chakravarty R; Sarma HD; Dash A Cancer Biother Radiopharm; 2014 Jun; 29(5):200-9. PubMed ID: 24852244 [TBL] [Abstract][Full Text] [Related]
6. Personnel exposure in labelling and administration of (177)Lu-DOTA-D-Phe1-Tyr3-octreotide. Sghedoni R; Grassi E; Fioroni F; Asti M; Piccagli V; Versari A; Iori M Nucl Med Commun; 2011 Oct; 32(10):947-53. PubMed ID: 21876406 [TBL] [Abstract][Full Text] [Related]
7. Superficial skin cancer therapy with Y-90 microspheres: A feasibility study on patch preparation. Pashazadeh A; Landes R; Boese A; Kreissl MC; Klopfleisch M; Friebe M Skin Res Technol; 2020 Jan; 26(1):25-29. PubMed ID: 31338896 [TBL] [Abstract][Full Text] [Related]
8. Formulation and characterization of lutetium-177-labeled stannous (tin) colloid for radiosynovectomy. Arora G; Singh M; Jha P; Tripathy S; Bal C; Mukherjee A; Shamim SA Nucl Med Commun; 2017 Jul; 38(7):587-592. PubMed ID: 28538080 [TBL] [Abstract][Full Text] [Related]
10. A systematic study on the utility of CHX-A''-DTPA-NCS and NOTA-NCS as bifunctional chelators for Pandey U; Gamre N; Lohar SP; Dash A Appl Radiat Isot; 2017 Sep; 127():1-6. PubMed ID: 28478331 [TBL] [Abstract][Full Text] [Related]
11. Utilization of Chemical Deposition Technique for Preparation of Miniature Kumar M; Pandey U; Yadav Y; Gandhi SS; Saxena SK; Kumar Y; Nuwad J; Dash A Cancer Biother Radiopharm; 2019 Feb; 34(1):24-32. PubMed ID: 30277805 [TBL] [Abstract][Full Text] [Related]
12. Radiation Dosimetry Aspects of (177)Lu. Lassmann M; Eberlein U Curr Radiopharm; 2015; 8(2):139-44. PubMed ID: 25771372 [TBL] [Abstract][Full Text] [Related]
13. Studies on 177Lu-labeled methylene diphosphonate as potential bone-seeking radiopharmaceutical for bone pain palliation. Abbasi IA Nucl Med Biol; 2011 Apr; 38(3):417-25. PubMed ID: 21492790 [TBL] [Abstract][Full Text] [Related]
14. Tumoral fibrosis effect on the radiation absorbed dose of (177)Lu-Tyr(3)-octreotate and (177)Lu-Tyr(3)-octreotate conjugated to gold nanoparticles. Azorín-Vega EP; Zambrano-Ramírez OD; Rojas-Calderón EL; Ocampo-García BE; Ferro-Flores G Appl Radiat Isot; 2015 Jun; 100():96-100. PubMed ID: 25305748 [TBL] [Abstract][Full Text] [Related]
15. Production, quality control, and determination of human absorbed dose of no carrier added Salek N; Mehrabi M; Shirvani Arani S; Bahrami Samani A; Erfani M; Vosoghi S; Ghannadi Maragheh M; Shamsaei M J Labelled Comp Radiopharm; 2017 Jan; 60(1):20-29. PubMed ID: 27862203 [TBL] [Abstract][Full Text] [Related]
17. Formulation, preclinical evaluation, and preliminary clinical investigation of an in-house freeze-dried EDTMP kit suitable for the preparation of 177Lu-EDTMP. Das T; Sarma HD; Shinto A; Kamaleshwaran KK; Banerjee S Cancer Biother Radiopharm; 2014 Dec; 29(10):412-21. PubMed ID: 25409337 [TBL] [Abstract][Full Text] [Related]
18. Development of a ¹⁷⁷Lu-labeled RGD derivative for targeting angiogenesis. Ju CH; Jeong JM; Lee YS; Kim YJ; Lee BC; Lee DS; Chung JK; Lee MC; Jeong SY Cancer Biother Radiopharm; 2010 Dec; 25(6):687-91. PubMed ID: 21204763 [TBL] [Abstract][Full Text] [Related]
19. Intratumorally Injected 177Lu-Labeled Gold Nanoparticles: Gold Nanoseed Brachytherapy with Application for Neoadjuvant Treatment of Locally Advanced Breast Cancer. Yook S; Cai Z; Lu Y; Winnik MA; Pignol JP; Reilly RM J Nucl Med; 2016 Jun; 57(6):936-42. PubMed ID: 26848176 [TBL] [Abstract][Full Text] [Related]